Used in research as a selective inhibitor of Pim kinases, which are involved in cell signaling pathways related to cancer progression. Shows potential in studies targeting hematologic malignancies and solid tumors due to its ability to induce apoptosis and inhibit tumor cell proliferation. Investigated for its role in combination therapies with other anticancer agents to enhance treatment efficacy. Not approved for clinical use; strictly for laboratory research.